Efficacy and safety of Naoxintong capsule for treating chronic stable angina: study protocol for a randomized controlled trial

BACKGROUND: Cardiovascular disease is the leading cause of mortality and morbidity worldwide, Chronic stable angina (CSA) is the main symptom of myocardial ischemia, causes increased risk of major cardiovascular events such as sudden cardiac death and myocardial infarction. Naoxintong (NXT) capsule...

Descripción completa

Detalles Bibliográficos
Autores principales: Huanjia, Gao, Hairong, Cai, Jieqin, Zhuang, Xingzhen, Dai, Xue, Fu, Weizhang, Zhang, Bojun, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112004/
https://www.ncbi.nlm.nih.gov/pubmed/33971940
http://dx.doi.org/10.1186/s13063-021-05264-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112004/
https://www.ncbi.nlm.nih.gov/pubmed/33971940
http://dx.doi.org/10.1186/s13063-021-05264-y

Ejemplares similares